mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression
Launched by KAISER PERMANENTE · Jan 10, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women seeking prenatal care at KPNC
- • Identify as Black or Latina
- • Current prenatal PHQ-9 score 10-19
- • Gestational age \<30 weeks
- • Owns a smartphone or computer with internet access
- • English- or Spanish-speaking
- Exclusion Criteria:
- • Regular (3 times per week or more) stress reduction practice
- • Cognitively impaired
- • Deaf
About Kaiser Permanente
Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oakland, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials